Clinical Trials Sponsored by CannaXan GmbH

Total 3290 results

Urovant Sciences GmbH

Recruiting

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC (KANGUROO)

Neurogenic Detrusor Overactivity

United States
Valbiotis
BioTeSys GmbH

Recruiting

To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure (INSIGHT-2)

Elevated Blood Pressure

Germany
Kliniken Beelitz GmbH

Recruiting

Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients (EMST-PS)

Parkinson Disease | Multiple System Atrophy | Progressive Supranuclear Palsy

Germany
Biofrontera Bioscience GmbH

Recruiting

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults

Acne Vulgaris

United States
Leberstiftungs-GmbH Deutschland

Recruiting

German SLD-Registry (Deutsches SLD-Register)

Steatotic Liver Disease

Germany
AGO Research GmbH

Recruiting

WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (WoO)

Epithelial Ovarian Cancer

Germany
Stryker Trauma GmbH

Recruiting

INFINITY™ With ADAPTIS™ Technology Study (ITAR2)

Arthritis, Rheumatoid

United States
Hookipa Biotech GmbH

Recruiting

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

HPV-Related Squamous Cell Carcinoma

United States, Spain, Netherlands
Stryker Trauma GmbH

Recruiting

Elbow Outcomes Clinical Study (WELBOW) (WELBOW)

Orthopedic Disorder

Canada, France, Belgium, United Kingdom, Sweden
CENTOGENE GmbH Rostock

Recruiting

Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM) (iPSC-IEM)

Inborn Errors of Metabolism

Pakistan
GWT-TUD GmbH

Recruiting

Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML (PALOMA)

AML | MDS

Germany, Austria
Ced Service GmbH

Not yet recruiting

TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners (TARGET)

Crohn Disease | Ulcerative Colitis | Indeterminate Colitis
Segeberger Kliniken GmbH

Recruiting

The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s

Coronary Artery Disease

Germany
CENTOGENE GmbH Rostock

Recruiting

Rostock International Parkinson's Disease Study (ROPAD) (ROPAD)

Parkinson´s Disease

Spain, Israel, United Kingdom, United States, Germany, Albania, Belgium, Brazil, Canada, France, Greece, Italy, Portugal, Turkey, Norway
Segeberger Kliniken GmbH

Recruiting

The Prospective Segeberg TAVI Registry (POST-TAVI)

Aortic Valve Stenosis

Germany
Translumina GmbH
EVAMED

Active, not recruiting

Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems (YuChooSeR)

Coronaropathy

France
Heidelberg Engineering GmbH

Completed

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

Cataract | IOL | Healthy Eye | Cornea Abnormality | Post-Keratorefractive Surgery

United States
Biofrontera Bioscience GmbH

Active, not recruiting

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Superficial Basal Cell Carcinoma

United States
Valneva Austria GmbH

Completed

Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
Urovant Sciences GmbH

Completed

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Overactive Bladder

United States, Poland
GWT-TUD GmbH

Active, not recruiting

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry (PERI-DYS)

Dyslipoproteinemias

Germany
Galderma Laboratorium GmbH

Completed

ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

Actinic Keratoses

Germany
T-knife GmbH

Terminated

A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors (IMAG1NE)

Advanced Solid Tumors

Germany, Belgium, Spain, Netherlands, United Kingdom
CENTOGENE GmbH Rostock

Active, not recruiting

Epidemiological Study in FRONtoTemporal Dementia (EFRONT)

Frontotemporal Dementia

Italy, Spain, Belgium, Turkey, Portugal, Germany, Greece
Stryker Trauma GmbH

Active, not recruiting

Pyrocarbon Clinical Follow-up Study (PYC CFS)

Avascular Necrosis | Traumatic Arthritis | Osteoarthritis of the Shoulder

United States
G.ST Antivirals GmbH

Completed

Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers

Acute Nasopharyngitis

Austria
Valneva Austria GmbH

Completed

Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

SARS-CoV-2 Virus Infection

New Zealand
Myovant Sciences GmbH

Completed

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

Endometriosis

United States, Spain, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, Poland, Portugal, South Africa, Ukraine, Australia, Brazil, Chile, Italy, New Zealand, Romania, Georgia
DKMS gemeinnützige GmbH

Active, not recruiting

Haploidentical Donor vs mMUD in Hematological Malignancies (HAMLET)

AML | MDS | ALL

Germany
Valneva Austria GmbH

Completed

Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

Chikungunya Virus Infection

United States
zr Pharma & GmbH

Completed

A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma

United States, Israel
zr Pharma & GmbH

Completed

Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib (AME)

Solid Tumor

Hungary
MVZ Leopoldina GmbH

Completed

Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy

Breast Cancer

Germany
Biofrontera Bioscience GmbH

Completed

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Keratosis | Actinic Keratosis | Keratosis, Actinic

United States
Urovant Sciences GmbH

Completed

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Overactive Bladder With Urge Urinary Incontinence

United States
Vital Solutions GmbH

Active, not recruiting

Investigation of Benegut® on Immediate GI Discomfort Relief Caused by Acute Overfeeding in Healthy Subjects

Healthy Volunteers

Germany
BlueSky Immunotherapies GmbH

Enrolling by invitation

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

HPV Infection | Safety Issues

Austria
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hypophosphatasia Disease (BioHypophos) (BioHypophos)

Defective Mineralization

Germany, Sri Lanka, India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hurler Disease (BioHurler) (BioHurler)

Metabolism, Inborn Errors | Mucopolysaccharidosis Type I | Gargoylism

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Farber Disease (BioFarber) (BioFarber)

Splenomegaly | Hepatomegaly | Ceramidase Deficiency | Farber's Lipogranulomatosis

Germany, India, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Sly Disease (MPS VII) (BioSly) (BioSly)

Developmental Delay | Splenomegaly | Hepatomegaly | Skeletal Abnormalities

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Krabbe Disease (BioKrabbe) (BIOKRABBE)

Krabbe Disease

Egypt, Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease (BioMeta)

Muscle Weakness | Peripheral Neuropathy

Egypt, Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) (BioSanfilippo)

Developmental Delay | Mental Retardation

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Wolman Disease (BioWolman) (BioWolman)

Cholesterol Ester Storage Disease | Acid Lipase Deficiency | Acid Cholesteryl Ester Hydrolase Deficiency, Wolman Type

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Completed

Peptide-based Immunization for Colon- and and Pancreas-carcinoma (PICOP-GLOBAL)

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Rectal Cancer | Rectal Neoplasms | Colon Cancer | Pancreas Cancer | Colo-rectal Cancer | Rectal Adenocarcinoma | Colon Neoplasm | Rectal Tumors | Colon Adenocarcinoma

Pakistan
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) (BioTRAP)

Transthyretin Amyloidosis | Transthyretin Amyloid Cardiopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

India, Germany
CENTOGENE GmbH Rostock

Terminated

Biomarker for Alport Syndrome (BioAlport) (BioAlport)

Nephritis, Hereditary | Hematuria-Nephropathy-Deafness Syndrome

India, Sri Lanka, Albania, Georgia, Lithuania, Pakistan, Romania
CENTOGENE GmbH Rostock

Terminated

Biomarkers for Hunter Syndrome (BioHunter)

Mucopolysaccharidosis II | Hunter Syndrome | Hunter's Syndrome, Mild Form | Hunter's Canal Syndrome

Mexico
CENTOGENE GmbH Rostock

Completed

Pyruvate Kinase Deficiency Epidemiological Study (PIECE) (PIECE)

Pyruvate Kinase Deficiency

United States

Clinical Trials Sponsored by CannaXan GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations